140-149
Surveillance of ESBL producing multidrug resistant Escherichia coli in a teaching hospital in India
Authors: Shakti Rath, Debasmita Dubey, Mahesh C. Sahu, Rabindra N Padhy
Number of views: 328
Objective: To record nosocomial and community-acquired accounts of antibiotic resistance
in Escherichia coli (E. coli) strains, isolated from clinical samples of a teaching hospital by
surveillance, over a period of 39 months (November 2009-January 2013).
Methods: Clinical samples from nosocomial sources, i.e., wards and cabins, intensive care
unit (ICU) and neonatal intensive care unit (NICU), and community (outpatient department, OPD)
sources of the hospital, were used for isolating strains of E. coli, which were subjected for testing
for production of ‘extended spectrum beta-lactamase’-(ESBL) enzyme as well as determining
antibiotic sensitivity pattern with 23 antibiotics.
Results: Of the total 1642 (100%) isolates, 810 (49.33%) strains were from OPD and 832 (50.66%)
were from hospital settings. Occurrence of infectious E. coli strains increased in a mathematical
progression in community sources, but in nosocomial infections, such values remained almost
constant in each quarter. A total of 395 (24.05%) ESBL strains were isolated from the total 810
isolates of community; of the total of 464 (28.25%) isolates of wards and cabins, 199 (12.11%) were
ESBL strains; and among the total of 368 (22.41%) isolates of ICU and NICU, ESBLs were 170 (10.35%);
the total nosocomial ESBL isolates, 369 (22.47%) were from the nosocomial total of 832 (50.66%)
isolates. Statistically, it was confirmed that ESBL strains were equally distributed in community
or hospital units. Antibiogram of 23 antibiotics revealed progressive increases of drug-resistance
against each antibiotic with the maximum resistance values were recorded against gentamicin:
92% and 79%, oxacillin: 94% and 69%, ceftriaxone: 85% and 58%, and norfloxacin 97% and 69%
resistance, in nosocomial and community isolates, respectively.
Conclusions: This study revealed the daunting state of occurrence of multidrug resistant E. coli
and its infection dynamics in both community and hospital settings.